Who Owns NVCT?

Nuvectis Pharma, Inc. — Institutional Ownership & 13F Holdings

$8.75

-0.15 (-1.69%)

Market Cap

$240.5M

Shares Outstanding

26,491,701

Institutional Holders

33

Total Inst. Value

$18.7M

% of Float Held

QoQ Holder Change

-4

Institutional data as of Q1 2025

New Positions

10

Closed Positions

7

Increased

13

Decreased

3

Institutional Ownership Trend

Top 10 Institutional Holders(Q1 2025)

#FundValueShares
1VANGUARD GROUP INC$4.6M467,419
2BALDWIN WEALTH PARTNERS LLC/MA$3.5M358,461
3IRIDIAN ASSET MANAGEMENT LLC/CTNew$2.5M253,972
4GEODE CAPITAL MANAGEMENT, LLC$1.3M135,333
5UBS Group AG$1.1M111,520
6BlackRock, Inc.$669K68,484
7FORBES J M & CO LLP$576K59,000
8GOLDMAN SACHS GROUP INCNew$446K45,608
9Austin Wealth Management, LLCNew$441K40,250
10JANE STREET GROUP, LLCNew$413K42,299

Biggest Buyers & Sellers This Quarter

Top Buyers

Top Sellers

FundShares RemovedValue
MARSHALL WACE, LLP-86K$380K
Squarepoint Ops LLC-8K$108K
BNP PARIBAS FINANCIAL MARKETS-13$0

Related Stocks

Frequently Asked Questions

How many institutional investors hold NVCT?

As of Q1 2025, 33 institutional investors report holding NVCT (Nuvectis Pharma, Inc.) in their 13F filings.

Which hedge fund owns the most NVCT?

The largest institutional holder of NVCT is VANGUARD GROUP INC with $4.6M in shares.

Are institutions buying or selling NVCT?

This quarter, 10 institutions opened new positions in NVCT and 7 closed their positions.

What is 13F institutional ownership?

SEC Form 13F is a quarterly report filed by institutional investment managers with over $100M in qualifying assets. It discloses their US equity holdings, providing transparency into what the largest investors are buying and selling.

How often is institutional ownership data updated?

13F filings are due 45 days after each calendar quarter end (May 15, Aug 14, Nov 14, Feb 14). Data is updated on HedgeTrace as new filings are processed.